Table 2.

Prevalence (and 95% confidence intervals) of clinically actionable elevated alanine aminotransferase (ALT) level in children with obesity

	All Groups	Asian/PI	Black	Hispanic	White
Males	10.0% (9.3-10.7)	10.4% (8.8-12.0)	3.1% (1.6-4.6)	12.0% (10.9-13.1)	7.3% (5.9-8.7)
Moderate Obesity	6.9% (6.1-7.7)	7.1% (5.5-8.8)	1.7% (0.0-3.4)	8.4% (7.2-9.7)	4.9% (3.4-6.4)
Severe Obesity	14.1% (12.9-15.3)	16.7% (13.4-20.0)	4.3% (1.9-6.6)	16.3% (14.5-18.2)	10.7% (8.1-13.3)
Females	5.0% (4.4-5.5)	7.7% (5.8-9.7)	1.7% (0.8-2.6)	6.1% (5.2-7.0)	3.4% (2.3-4.4)
Moderate Obesity	3.4% (2.8-4.0)	5.4% (3.5-7.4)	1.0% (0.0-2.1)	3.8% (2.9-4.7)	2.6% (1.5-3.7)
Severe Obesity	7.4% (6.3-8.4)	13.4% (8.8-18.0)	2.3% (0.8-3.7)	9.5% (7.8-11.2)	4.7% (2.8-6.7)

Clinically actionable elevated ALT level was defined according to the NASPGHAN guidelines: ≥44 U/L for girls and ≥52 U/L for boys (5)

PI = Pacific Islander